UBS Group’s Charming Medical Ltd MCTA Stock Holding History

UBS Group’s Portfolio MCTA Stock Details MCTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$712K	Sell	24,249 -700	-3%	-$20.5K	﹤0.01%	5995
2026 Q1	$732K	Sell	24,949 -3,300	-12%	-$96.9K	﹤0.01%	5788
2025 Q4	$829K	Buy	+28,249	New	+$510K	﹤0.01%	5729

Other funds holding MCTA

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's MCTA Position: Q2 2026 in Review

UBS Group reduced its Charming Medical Ltd (MCTA) stake by 2.8% in Q2 2026, selling an estimated $20.5K and leaving 24,249 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #5995.

UBS Group first reported a position in MCTA in Q4 2025 and has held it in 3 quarters since. The position peaked at $829K in Q4 2025. 3 funds tracked by Wall St. Rank hold MCTA as of Q2 2026.

UBS Group held 24,249 shares of Charming Medical Ltd worth $712K as of Q2 2026.
UBS Group sold 700 Charming Medical Ltd shares in Q2 2026, an estimated $20.5K.
Charming Medical Ltd made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5995 holding.
UBS Group first reported a position in Charming Medical Ltd in Q4 2025 and has held it in 3 quarters since.
UBS Group's Charming Medical Ltd position peaked at $829K in Q4 2025.
3 funds tracked by Wall St. Rank held Charming Medical Ltd as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.